lhcqf logo 2016
home-3-top-images-temp

Prazosin

Jeffrey A Brinker, M.D.

Jeffrey A Brinker, M.D.

  • Professor of Medicine
  • Joint Appointment in Radiology and Radiological Science

https://www.hopkinsmedicine.org/profiles/results/directory/profile/0001297/jeffrey-brinker

The treatment cycle was repeated at approximately six-week intervals for up to three additional times buy cheap prazosin 1 mg line cholesterol chart mayo clinic, for a maximum of 8 total injection procedures and 4 total modeling procedures purchase prazosin with a visa does cholesterol ratio 2.3 mean. In addition generic prazosin 2mg without prescription cholesterol levels per age, patients were instructed to perform penile modeling at home for six weeks after each treatment cycle. The percentage improvement in curvature deformity was numerically similar among patients with baseline deformity from 30 to 60 degrees and those with curvature deformity from 61 to 90 degrees. The reduction in the Bother domain score was numerically similar between patient groups stratified by degree of baseline curvature deformity (30 to 60 degrees and 61 to 90 degrees). Table 13 provides the baseline disease characteristics for the study population and Tables 7-8 provide the results of the co-primary efficacy endpoints measured in the 2 double-blind placebo-controlled studies 1 and 2. Purified collagenase Clostridium histolyticum was not mutagenic in Salmonella typhimurium (Ames test) and was not clastogenic in both an in vivo mouse micronucleus assay and an in vitro chromosomal aberration assay in human lymphocytes. Collagenase Clostridium histolyticum did not impair fertility and early embryonic development when administered intravenously in rats at doses up to 0. Storage condition of the reconstituted medicinal product: After reconstitution the solution can be used immediately. We also need toll with stress, aging, our preferred stimulation which 1 | Not much if it is well controlled. And difculties, anxiety and we need the capability to respond, Everything if it is not well controlled. It may also be associated backs up into the bladder rather with certain medications for high than being ejected out the penis. Peronies disease: this condition which causes a painful curvature of the penis is caused by plaque build up in an artery of the penis. Those who have diabetes run an increased risk for developing problems with depression and anxiety. Here is a brief list to check before you assume the cause is not if related to your diabetes. Increased difculty achieving If you run through this list and feel orgasm: this is associated with reasonably good about what you neuropathy. Here are some questions that Sex therapist might help them identify what is happening to you. These questions are hard because most people are not used to talking about sex, but to get Relationship therapist the help you want it will be important to be this clear. For example, do you not get an have a diferent set of ideas of how erection any time, ever? Or do you get no erections with partner so you may want to start with your stimulation but get occasional morning erections. Every time, only some of the time, Be assured there are treatments when you are stressed? More stimulation, diferent restore functioning and some may stimulation, more time in foreplay? There is activity requires you and your heart evidence to suggest that sexual to be in good shape. So in addition problems for both men and women to being sexual, get some other with diabetes are similar to other physical activity during your week. These muscles mindful of what you eat and drink, are very important in enhancing test regularly, and take your medi- your sexual experience. One of the most assure you are doing your part to efective ways to maintain an protect this aspect of your health. This In the short term make sure your old adage holds true because when blood sugar is in your target range we have sex certain hormones are before you start sexual play. Noth- produced that make us feel good at ing is worse than having low blood the time and also increase our sugar during sex, or having it be so desire to engage again sooner. If high that it interferes with your we stop having sexual play we current arousal. Redefne sex, have a lot of foreplay, For most couples they learn what take your time. Because the sexual works to meet their sexual needs difculties with diabetes may be and then they use this activity primarily associated with arousal, forever. This becomes so familiar it foreplay activity may be helpful for can lead to boredom. Take time for does mean you discuss trying a play time, outer-course, before diferent position or a diferent type intercourse. Something new may If you are having difculty with any restore some freshness and aspect of your sex life, see a profes- improve both interest and function. There are is adult play and if you are not many treatments that can be help- having fun perhaps you need ful, but having someone to talk with something to change. If sex creates about your concerns may be all you anxiety, or functionally you are need. If you require more at least having a hard time getting things to you have started the process. Even work, it might be time to talk with if you decide to not use the treat- your diabetes educator, doctor or a ments, at least you will have the sex therapist. Plan it and do it because it is good for the relation- ship and ultimately it will be good for your sex life too. Chapter 11: the Priapus Shot (P-Shot) Chapter 12: Other Benefits of Platelet Rich Plasma References About the Author If you want to learn more about Platelets Rich Plasma and its healing power go to: bit. The publisher and author make no representation or warranties with respect to accuracy or completeness of the content of this work and specifically disclaim all warranties. The author and the publisher will neither have liability or responsibility to any person with respect to any loss, damage, or injury caused or alleged to be caused directly or indirectly by the information in this book. The intent of this book is not to dispense medical advice or prescribe the use of any techniques as a formal treatment for any physical medical conditions or psychological or emotional problems, without advice of a physician either directly or indirectly taking care of the individual.

cheap prazosin online american express

discount 1mg prazosin visa

Results of Studies Addressing Interventions to Overcome Barriers to the Appropriate Use of Therapies A summary of the results of studies addressing interventions to increase the appropriate use ∗ of therapies is provided in Table 10 (see also Appendix C order prazosin 2mg on line cholesterol levels uk, Evidence Tables 27 and 28) prazosin 1mg fast delivery cholesterol levels ketogenic diet. Four of the studies that measured the impact of an intervention to improve the quality of pain management during vaso-occlusive crisis showed improvement in one or more direct outcomes purchase cheap prazosin on line cholesterol levels of 200, 173,179,180,185 while the remaining five studies showed potential improvement either through the suggestion of an improvement on a direct outcome (without a statistical test) or a statistically significant improvement in one or more indirect outcomes. Two of the three studies that focused on patient interventions to improve adherence to 181 therapies showed no effect of the intervention on patient adherence to desferoxime or to 182 antibiotic prophylactic therapy. One of the studies that focused on patient interventions to improve adherence to therapies showed no increase in health-promoting activities as a result of the intervention but did show some improvements in child health-related quality of life and 183 child-parent relationships. The one study that evaluated a patient intervention to improve receipt of routine, scheduled health care for sickle cell disease demonstrated a substantial and significant reduction in the 184 percent of patients who had not attended clinic over the past 2 years. The strength of the evidence addressing interventions to overcome barriers to the use of therapies. The evidence was insufficient to allow us to identify interventions to overcome barriers to the use of hydroxyurea and bone marrow transplantation. None of the three studies testing interventions to improve patient adherence to established therapies for chronic disease management showed any effect on patient adherence. However, due to the small sample sizes and diverse outcome measures, we concluded that there was only low- grade evidence that interventions cannot improve patient adherence. We concluded that there was moderate evidence that interventions can overcome barriers to the use of pain medications and moderate evidence to support the contention that interventions ∗ Appendixes cited in this report are provided electronically at:. Discussion Since its approval for the treatment of sickle cell disease in 1998, hydroxyurea has been under intense study. The body of evidence supporting its use is large but is mainly based on observational data. There have been only two randomized controlled trials of the use of this drug in sickle cell disease, although an additional large trial is nearing completion. The other studies of this drug have included several controlled studies comparing patients receiving hydroxyurea to patients receiving another intervention or usual care, but the vast majority of the studies have been observational studies, including well-described prospective cohorts and many small studies reporting patient experiences pre- and post-treatment with hydroxyurea. In addition, the literature is replete with case reports describing toxicities ascribed to hydroxyurea, although the majority of these reports concern diseases other than sickle cell disease. Few studies have specifically identified barriers to the use of hydroxyurea in patients with sickle cell disease. No studies have tested an intervention to improve patient acceptance of this medication or patient adherence. For this report, we opted to review the literature related to barriers to the use of other medications and treatments in patients with sickle cell disease, since we believe that the barriers may often be similar. In this section, we describe key findings from our literature review, describe the limitations of this body of literature, and discuss the limitations of our report. We also describe studies that are in progress and make suggestions, based on the gaps in the current evidence, with regard to studies that should be undertaken in the future. In this Belgian study, the rate of hospitalization and number of days hospitalized per year were significantly 44 lower in the hydroxyurea group than in the placebo group. The small size of this study and the short duration of treatment with the drug (6 months) did not provide adequate data to permit assessment of the long-term responses to hydroxyurea. The results of this trial are supported by data from 20 observational studies in children. Interpretation of many of these observational studies is complicated by their incomplete description of losses to followup. The mean pre-treatment Hb F% ranged from 5 to 10 percent, and the post-treatment values were in the range of 15 to 20 percent. In the study of infants, hydroxyurea therapy prevented the expected decline in Hb F% that is usually seen in this 67 age group. Hemoglobin concentration increased only modestly (roughly 1 gm/dl) but significantly across studies. The frequency of pain crises decreased in three of the five studies in which this variable was assessed; in one study without a comparison group, it was unclear how the rate differed from an untreated group. One study included a control group that showed an increase in velocity over 62 the treatment period. One other study demonstrated rates of recurrent stroke in patients receiving hydroxyurea to be comparable to the rate typically seen in children on chronic 67 transfusion therapy. There was moderate evidence to support the contention that hydroxyurea reduces the frequency of pain crises, and a high grade of evidence that it reduces the frequency and/or duration of hospitalization in children. There was a low grade of evidence to support that claim that hydroxyurea reduces neurological events in children, and insufficient evidence to allow us to draw any conclusions regarding transfusion frequency. The significant hematological effects of hydroxyurea after 2 years (when compared to the placebo arm) included a small increase in total hemoglobin of 0. The median number of painful crises was 44 percent lower in the hydroxyurea arm, and the time to the first painful crisis was 3 months, as compared to 1. There were fewer episodes of acute chest syndrome and transfusions, but no significant differences in deaths, strokes/chronic transfusion, or hepatic sequestration. In all six studies of adults that reported hematological outcomes, Hb F% was 45 46,71,74,78,80 significantly higher for those receiving hydroxyurea. The number of pain crises was given in three studies, all of which demonstrated a significant decline in frequency with drug 46,61,71 treatment. In a group of patients treated for fewer than 24 months, however, the investigators did not find a 52 significant difference in hospitalization rates from baseline, although patients who discontinue before 24 months may represent a different population than those who are able to tolerate a longer duration of therapy. Several interesting studies have described potential biomarkers of the response to hydroxyurea. One study identified significantly decreased rigidity and rates of elastic shear in patients with sickle cell disease treated with hydroxyurea, when compared to untreated sickle cell disease patients, but the values were still significantly higher than those for controls without 85 sickle cell disease. Another study described lower rates of arginase activity in those treated with hydroxyurea, but again the rates were lower in controls without sickle cell disease. These studies suggest that other mechanisms may contribute to the benefit resulting from hydroxyurea in addition to the anti-sickling effect produced by an increase in Hb F concentration in red blood cells.

cheap prazosin 2mg with visa

There is some evidence that adjunctive penicilline treatment may enhance the clinical response to colchicine therapy for both oral and genital ulcers [129] discount prazosin 1 mg free shipping cholesterol ketosis. In an uncontrolled study buy prazosin 2 mg low price cholesterol test with finger prick, benzathine penicillin improved the clinical manifestations of disease order prazosin american express cholesterol medication comparison. In an retrospective study, benzathine penicilline had a beneficial effect on oral and genital ulcers. A prospective randomized study compared the efficacy of colchicine with colchicine and benzathine penicillin over 24 months. The number of arthralgia episodes was significantly reduced in the combination group and episode-free period was significantly prolonged with combination therapy. And they reported the effectiveness of benzathine penicilline and colchicine on the mucocutaneous manifestations, benefits not achieved with colchicine monotherapy [129-130]. The result of an open study with minocycline treatment for 3 months were reported and it was observed that oro-genital ulcers, erythema nodosum and papulopustular eruptions improved at a rate of %10 to 100 [131]. The hypothetical antiinflammatory effects of erythromycin, besides its antibiotic properties, explain such a clinical improvement [133]. Intermittant ascorbic acid treatment (vitamin C; 500mg/ day) is advisable to prevent increased methaemoglobin serum levels. Its use is often complicated by haemolytic anemia, even in patients with normal glucose-6-phosphate-dehyrogenase activity [105-106]. This book chapter is open access distributed under the Creative Commons Attribution 4. But, it should be reserved for the most severe patients because of its significant long-term adverse effects [30]. Discontinuation of the treatment results in oral and genital ulcers recurrences; therefore a maintenance treatment with 50 mg/day to 50 mg twice a week is recommended. Thalidomide is often highly effective at reducing the frequency and severity of mucocutaneous disease resistant to colchicine. However, its widespread use is clearly limited teratogenic and neuropathic complications. The risk of developing irreversible peripheral neuropathy is thought to increase in a dose-dependent fashion, and so thalidomide should be recommended at the lowest dose possible to control symptoms. Lactobacilli, which have anti-inflammatory activity, may be useful in some diseases, particularly in inflammatory bowel disease. Short- lived attacks of anterior uveitis can be managed with topical corticosteroids, either by eye drops or via orbital floor injections. Nonsteroidal anti-inflammatory drugs, such as topical indomethacin, diclofenac, and flurbiprofen, may prove useful as potentiators of corticosteroid activity, which allows corticosteroid dosage to be reduced and when the use of corticosteroids is contraindicated [30,36,37]. This book chapter is open access distributed under the Creative Commons Attribution 4. Prolonged episodes, or if posterior uveitis is present, should be treated with systemic corticosteroids, often using doses up to 1 mg/kg of prednisolone daily. Steroid sparing agents are generally instituted early in the course of significant ocular inflammation and may have to be used in combination to gain control of ocular disease [36-37]. In a single study, the rate of complete and partial remissions was %50 with corticosteroids, %66 with colchine, and %71 with azathiopurine. We believe that the low frequency of ocular involvement in our patients may be result of the beneficial effect of the colchicine therapy we initiated at the time of diagnosis, early in the course of the disease [2,4]. Azathiopurine and chlorambucil have also been reported to improve the long- term visual prognosis [57-113]. Mycophenolat mofetil has shown promise as an effective drug for managing uveitis refractory to treatment with azathiopurine and/or cyclosporin, usually at a dose of 1 gr in ocular involvement. These include serious infection, including tuberculosis, autoantibody production, and other respiratory, gastrointestinal, and dermatological symptoms. Interferon-α2a is most effective for ocular symptomes, in one study, it resulted in complete remission of ocular symptomes in %67 of the patients within four months. This book chapter is open access distributed under the Creative Commons Attribution 4. Intravenous infusions of immuneglobulins, plasmapheresis, and granulocytapheresis have also been tried in small numbers of patients, but the data are quite limited [148]. Fourteen patients were treated, each received one session/week over 5 consecutive weeks. Low-dose corticosteroids and azathiopurine are used in patients whose arthritis is resistant to treatment with nonsteroidal antiinlammatory drugs, colchicine or sulfasalazine. Arthrocentesis and intra-articular steroid injections may also be effective for severe monoarthritis [30]. Invazive surgical procedures often result in excessive infiltration of inflammatory cells into the treated tissues, with subsequent anastomotic leakage. To prevent this complication, indetermine doses of corticosteroids are given to the patients for several days after surgery. Even if the operation is successful, repeated operation because of recurrence is required in about half of the patients. Central nervous system lesions are usually treated with high-dose corticosteroids. This book chapter is open access distributed under the Creative Commons Attribution 4. Corticosteroids can be supplemented with cytotoxic agents such as cyclophosphamide, chlorambucil, and methotrexate [93].

best purchase for prazosin

Arrhythmogenic right ventricular dysplasia

buy discount prazosin 2 mg online

Since the mixture com- position varies along the length of the tube purchase cheap prazosin online cholesterol test edmonton, the density varies as well prazosin 2 mg discount cholesterol whey protein. However prazosin 1mg cholesterol test vhi, if we take the temperature and pressure to be constant, the molar concentration of the mixture does not change through the tube. The system is then most easily analyzed using the molar form of species conservation. For one-dimensional steady mass transfer, the mole fluxes N1 and N2 have only vertical components and depend only on the vertical coordi- nate, y. If the temperature and pressure can be taken as constant in the stagnant layer, so, too, can cD12. The first boundary condition is x1 = x1,s at y = 0 and it requires that constant =−ln(Nsx1,s − N1,s) (11. This ratio, which depends on the spe- cific problem at hand, can be fixed by considering the rates at which the species pass through the s-surface and forms the last boundary condi- tion. The e-surface in our analysis is at the mouth of the tube and the s-surface is just above the surface of the liquid. The gas flow over the top may contain some concentration of the liquid species, x1,e, and the vapor pressure of the liquid pool produces a concentration x1,s. Only vapor is transferred through the s-surface, since the gas is assumed to be essentially insoluble and will not be absorbed into gas-saturated liquid. Thus, N2,s = 0, and Ns = N1,s = Nvapor,s is just the evaporation rate of the liquid. The ratio N1,s/Ns is unity, and the rate of evaporation is cD12 x1,e − x1,s Ns = Nvapor,s = ln 1 + (11. In this case, we obtain a single equation for N1,s = Nvapor,s, the evaporation rate: cD12 x1,e − x1,s Ngas + N1,s = ln 1 + (11. Once we have found the mole fluxes, we may compute the concentra- tion distribution, x1(y), using eqn. Assume the helium stream at the top of the tube to have a mole fraction of water equal to 0. The vapor pressure of the liquid water is approximately the saturation pressure at the water temperature. The present analysis has two serious shortcomings when it is ap- plied to real Stefan tubes. First, it applies only when the evaporating species is heavier than the gas into which it evaporates. If the evaporat- ing species is lighter, then the density increases toward the top of the tube and buoyant instability can give rise to natural convection. Because a heat sink is associated with the latent heat of vaporization, the gas mixture tends to cool near the interface. The resulting temperature variations within the tube can affect the assump- tion that cD12 is constant and can potentially contribute to buoyancy effects as well. Since Stefan tubes are widely used to measure diffusion coefficients, the preservation of isothermal conditions has received some attention in the literature. A mass-based analysis of convection problems often becomes more convenient than a molar analysis because it can be related directly to the mass-averaged velocity used in the equations of fluid motion. The problem dealt with in this section can be solved on a mass basis, as- suming a constant value of ρD12 (see Problem 11. However, if the two species have greatly differing molecular weights or if the mixture composition changes strongly across the layer, then ρ can vary signifi- cantly within the layer and the molar analysis yields better results (see Problem 11. Nevertheless, the mass-based solution of this problem provides an important approximation in our analysis of convective mass transfer in the next section. However, because of the strong influence mass transfer can have on the convective velocity field, the flow effects of a mass flux from a wall must also be considered in modeling mass convection processes. The mass transfer coefficient is developed in three stages in this sec- tion: First, we define it and derive the appropriate driving force for mass transfer. Next, we relate the mass transfer coefficient at finite mass trans- fer rates to that at very low mass transfer rates, using a simple model for the mass convection boundary layer. Finally, we present the analogy between the low-rate mass transfer coefficient and the heat transfer co- efficients of previous chapters. In following these steps, we create the apparatus for solving a wide variety of mass transfer problems using methods and results from Chapters 6, 7, and 8. In the free stream, i has a concentration mi,e; at the wall, it has a concentration mi,s. This ratio is called the mass transfer driving force for species i: mi,e − mi,s Bm,i ≡ (11. If, for i,s example, n −n in a binary mixture, then m˙ is very small and 1,s 2,s both m1,t and m2,t are very large. The mass trans- fer rate may equally well be calculated using any species in a mixture; one obtains the same result for each. If species i is the only one passing through the wall, then n = m˙,so i,s that mt,i = 1. The evaporation of vapor from a liquid surface is an important example of single-species transfer. Only water vapor passes through the liquid surface, since air is not strongly absorbed into water under normal conditions. The most obvious way to do this would be to apply the same methods we used to find the heat transfer coefficient in Chapters 6 through 8—numerical or analytical solution of the momentum and species equations or direct ex- perimental simulation of the mass transfer problem.

Best purchase for prazosin. healthy nuts|healthy food guide |Simple healthy recipes| Heart healthy foods | healthy salad recipes.

Diagnostic Accuracy of Transesophageal Echocardiography discount prazosin online amex cholesterol in shrimp vs beef, Helical Computed Tomography buy prazosin visa cholesterol shot, and Magnetic Resonance Imaging for Suspected Thoracic Aortic Dissection: Systematic Review and Meta-analysis buy generic prazosin from india yolk cholesterol in eggs from various avian species. Page 213 of 885 9. Management of the severely atherosclerotic ascending aorta during cardiac operations. Distribution of Calcium in the Ascending Aorta in Patients Under- going Transcatheter Aortic Valve Implantation and Its Relevance to the Transaortic Approach. Evaluation of patients with paradoxical embolus/stroke and no evidence of patent foreman ovale on echocardiogram. Endovascular treatment of pulmonary and cerebral arteriovenous malformations in patients affected by hereditary haemorrhagic teleangiectasia. Non-urgent cases which do not meet above 2-step criteria, should undergo prior to advanced imaging: 9 1. Page 215 of 885 D. Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis. Prospective evaluation of right ventricular function and functional status 6 months after acute submassive pulmonary embolism: frequency of persistent or subsequent elevation in estimated pulmonary artery pressure. Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer. Prospective validation of Wells Criteria in the evaluation of patients with suspected pulmonary embolism. Page 216 of 885 8. Physical examination findings suggestive of subclavian stenosis include a discrepancy of >15 mmHg in blood pressure readings taken in both upper extremities, delayed or decreased amplified pulses in the affected side, and a bruit in the supraclavicular area on the affected side. Symptoms include vertebral basilar artery insufficiency, vertigo, limb paresis, and paresthesias. Bilateral cortical visual disturbances, ataxia, syncope, and dysarthria occur less frequently. If the carotid duplex is not diagnostic for reversal of flow in the ipsilateral vertebral artery, then neurological symptoms should be evaluated according to the Head guidelines. A current clinical evaluation (within 60 days) is required prior to considering advanced imaging. Appropriate laboratory studies and non-advanced imaging modalities, such as plain x-ray or ultrasound. Other meaningful contact (telephone call, electronic mail or messaging) by an established patient can substitute for a face-to-face clinical evaluation. A Pulmonary or Thoracic Surgical Specialist can be helpful in evaluating thoracic disorders. A recent chest x-ray (generally within the last 60 days) that has been over read by a radiologist would be performed in many of these cases prior to considering advanced imaging. Identify and compare with previous chest films to determine presence and stability. Chest x-ray can help identify previously unidentified disease and may direct proper advanced imaging for such conditions as: i. Page 220 of 885 b. The high resolution involves additional slices which are not separately billable. Clarification of some equivocal findings on previous imaging studies, which are often in the thymic mediastinal region or determining margin (vascular/soft tissue) involvement with tumor and determined on a case-by-case basis. Nuclear Medicine Quantitative differential pulmonary perfusion, including imaging when 78597 performed Quantitative differential pulmonary perfusion and ventilation (e. There is no evidence-based support for advanced imaging of clinically evidenced axillary lymphadenopathy without biopsy. Ultrasound directed core needle biopsy or surgical excisional biopsy of the most abnormal lymph node if condition persists or malignancy suspected. Excisional or ultrasound directed core needle biopsy of most abnormal lymph node if condition persists or malignancy suspected. Page 222 of 885. Ultrasound directed core needle biopsy or surgical excisional biopsy of the most abnormal lymph node if condition persists or malignancy suspected. Otherwise, imaging of other possible primary sites are led by symptomatology, and risk factors. Enlarged lymph nodes are in the mediastinum with no other thoracic abnormalities; and ii. Mediastinal Incidentalomas, Journal of Thoracic Oncology: August 2011, Volume 6, Issue 8 pp 1345-1349. Initial evaluation should include a recent chest x-ray after the current episode of cough started or changed. Cough in non-smoker after the following sequence for a total 3 week trial and investigation (all): a. For any abnormalities present on the initial chest x-ray, advanced chest imaging can be performed according to the relevant Chest Imaging Guidelines section 1.

References:

  • https://acc.com/sites/default/files/resources/vl/membersonly/ProgramMaterial/741285_1.pdf
  • https://www.esvs.org/wp-content/uploads/2015/12/CLTI-Guidelines-ESVS-SVS-WFVS.pdf
  • https://www.hopkinsmedicine.org/som/students/academics/catalog/somcat1112.pdf
  • http://www.egyptarch.gov.eg/sites/default/files/pdf/Books/Ceramic_and_Glass_Materials.pdf
  • https://minds.wisconsin.edu/bitstream/handle/1793/75653/NB_6061.pdf?sequence=1&isAllowed=y
 
 
footer-top-line
> CONTACT INFORMATION

    Louisiana Health Care Quality Forum

    8550 United Plaza Blvd., Ste. 301
    Baton Rouge, Louisiana 70809

    info@lhcqf.org
    Ph (225) 334-9299 | Fax 225-334-9847

facebook-logotwitter-logolinkedin-logoyoutube-logo
 
side-nav-off 01
side-nav-off 02
side-nav-off 03
side-nav-off 04
 

Loading